GPS Participações e Empreendimentos S.A. (GGPS3) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
13 Nov, 2025Executive summary
Net revenue reached BRL 4,462 million in Q3 2025, up 8% year-over-year, with 10% organic growth driven by new contracts and acquisition synergies, notably GRCA.
Adjusted EBITDA was BRL 435 million, up 3% year-over-year, with a 9.8% margin, slightly below target due to higher implementation and integration costs.
Adjusted net profit was BRL 188 million, 6% higher year-over-year, with a net margin of 4.2%.
Growth strategy combines organic expansion and acquisitions, with recent integration of GRCA, RH Med, NutriCard, and Grupo Tagg.
Financial highlights
Net revenue for 9M25 totaled BRL 12,865 million, up 20% year-over-year, with 7% organic growth.
Adjusted EBITDA for 9M25 was BRL 1,241 million, up 12% year-over-year, with a 9.6% margin.
Adjusted net profit for 9M25 was BRL 524 million, up 2% year-over-year, with a 4.1% margin.
Operational cash flow in Q3 was BRL 1,300 million, representing 106% of adjusted EBITDA.
Outlook and guidance
Organic growth is expected to normalize to high single digits (8-10%) in coming quarters, with Q3's double-digit growth seen as unsustainable long-term.
Margin improvement is targeted, especially for GRCA, aiming for double-digit EBITDA margins by end of 2025 and into 2026.
M&A activity is set to accelerate, with a robust pipeline and leverage at a comfortable 1.5x net debt/EBITDA.
Management remains focused on growth and risk management amid ongoing market challenges.
Latest events from GPS Participações e Empreendimentos S.A.
- Net revenue up 17% in 2025, with margin resilience and strong M&A-driven growth.GGPS3
Q4 20256 Mar 2026 - Revenue up 34% and EBITDA up 21%, with integration and margin focus ahead.GGPS3
Q1 20253 Feb 2026 - Revenue and EBITDA up 34% and 16%, but leverage and margin pressures persist post-GRSA.GGPS3
Q2 20242 Feb 2026 - Net revenue up 56% in 3Q24, led by acquisitions and organic growth, with margin pressure persisting.GGPS3
Q3 202415 Jan 2026 - Revenue up 39% to R$14.8B, but margins and ROIC declined amid major acquisitions.GGPS3
Q4 202416 Dec 2025 - Net revenue up 23%, EBITDA up 16%, leverage at 1.6x, but margins pressured by integration costs.GGPS3
Q2 202523 Nov 2025